Agnirva Space Premier League - Expedition #32085: Combating Muscle Atrophy in Space with Myostatin Inhibition

Skeletal muscle atrophy and weakness are significant challenges faced by astronauts during long-duration space missions due to the effects of microgravity. The experiment titled 'Assessment of myostatin inhibition to prevent skeletal muscle atrophy and weakness in mice exposed to long-duration spaceflight' is focused on finding a potential solution for this issue. Led by Dr. Rosamund Smith from Eli Lilly and Company, this study uses mice as models to test the impact of inhibiting myostatin, a protein that negatively regulates muscle growth, in preventing muscle loss in microgravity conditions. Conducted during NASA's Expedition 45/46 and 47/48, this experiment aims to identify therapeutic interventions that could help astronauts maintain muscle mass and strength during extended space missions. Beyond space exploration, this research could have far-reaching applications for treating conditions like muscle wasting associated with aging, chronic diseases, and even disuse atrophy in the general population. The success of myostatin inhibition could offer a novel approach to preserving muscle health in extreme environments, including outer space and Earth-bound medical contexts.

Get certified with over 100 hours of immersive, self-paced learning in astronomy, cosmology, space technology, and climate science through the Agnirva Space Internship Program. Join, complete virtual projects, and earn a digital certificate to showcase your space fluency in interviews, resumes, and beyond.